IL2 Mouse Monoclonal Antibody [Clone ID: OTI2C9]

CAT#: TA810724

IL2 mouse monoclonal antibody,clone OTI2C9

Product images

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IL2 (RC210013, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IL2. (1:200) (1:500). Positive lysates LY424619 (100ug) and LC424619 (20ug) can be purchased separately from OriGene.

• 

  Immunohistochemical staining of paraffin-embedded Carcinoma of Human liver tissue using anti-IL2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120°C for 3min, TA810724) (1:2000)

• 

  Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-IL2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120°C for 3min, TA810724) (1:2000)

Specifications

Product Data

• Clone Name: OTI2C9
• Applications: IHC, WB
• Recommended Dilution: WB 1:500, IHC 1:2000
• Reactivity: Human
• Host: Mouse
• Isotype: IgG2b
• Clonality: Monoclonal
• Immunogen: Human recombinant protein fragment corresponding to amino acids 21-153 of human IL2 (NP_000577) produced in E.coli.
• Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
• Concentration: 1 mg/ml
• Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Predicted Protein Size: 17.4 kDa
• Gene Name: interleukin 2
• Database Link:
  NP_000577
  Entrez Gene 3558 Human
• Synonyms: IL-2; lymphokine; TCGF

Reference Data

• Protein Families: Druggable Genome, Secreted Protein
• Protein Pathways: Allograft rejection, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Graft-versus-host disease, Jak-STAT signaling pathway, T cell receptor signaling pathway, Type I diabetes mellitus